Roche Holding AG ( RHHBY) - Stock Earnings
RHHBY Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| July 23, 2026, midnight | — / — | — | — / — | — |
RHHBY Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022Q2 | 8.9 billion USD | 33.8 billion USD |
| 2022Q3 | 1.9 billion CHF | 16.1 billion CHF |
| 2022Q4 | 4.2 billion USD | 33.5 billion USD |
RHHBY Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2021 | 15.3 billion USD | 68.9 billion USD |
| 2022 | 13.4 billion USD | 68.4 billion USD |
| 2023 | 13.7 billion USD | 71.9 billion USD |
RHHBY
Price: $50.96
Dividend Yield: 2.92%
Forward Dividend Yield: 3.13%
Payout Ratio: 71.80%
Dividend Per Share: 1.59 USD
Earnings Per Share: 2.60 USD
P/E Ratio: 22.25
Exchange: OQX
Sector: Healthcare
Industry: Drug Manufacturers - General
Country: Switzerland
Volume: 1.5 million
Ebitda: 21.5 billionMarket Capitalization: 341.6 billion
Average Dividend Frequency: 1
Years Paying Dividends: 34
DGR3: 3.32%
DGR5: 3.59%
DGR10: -1.01%
DGR20: 0.31%